Advertisement

Topics

Juno Therapeutics, Inc. Company Profile

11:35 EDT 26th September 2018 | BioPortfolio

About Opus Bio


News Articles [751 Associated News Articles listed on BioPortfolio]

Juno Therapeutics Spinout Raises $90M

JW Therapeutics, a clinical stage biopharma company founded by Juno Therapeutics and WuXi AppTec Group, has closed a Series A financing worth $90 million.

JW, a Juno-WuXi AppTec China JV, Raises $90 Million for CAR-T Drugs

JW Therapeutics of Shanghai closed an impressive $90 million Series A financing with the goal of bringing best-in-class immunotherapies to China. JW is a joint venture formed by Seattle's Juno Therape...

Juno Therapeutics And Agios: Two Really Big Fish That Got Away

As an early-stage VC, you miss some big ones. The author explores two big early stage biotech deals he missed, Agios and Juno, with some reflections on how they went down.

Juno CEO and Co-founder steps down in wake of Celgene acquisition

Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown it more than 500 employees, is to step down from his role now that his company has been a...

Juno’s Fontenot Joins Immusoft as Chief Scientific Officer

Jason Fontenot has been appointed chief scientific officer of Seattle cell therapy developer Immusoft. Fontenot most recently worked at Seattle cancer immunotherapy company Juno Therapeutics, which wa...

JW Therapeutics brings in $90mm through Series A round

JW Therapeutics (Shanghai) Co. Ltd. (cell-based immunotherapies for cancer) raised $90mm through its Series A round. Investors included Temasek, Sequoia Capital China, YuanMig Capital, Oriza Seed Capi...

Effortel, een van 's werelds toonaangevende mondiale MVNE's, selecteert JUNO Software voor de ...

BOEKAREST, Roemenië, September 13, 2018 /PRNewswire/ -- Effortel, de bekroonde mondiale MVNE [Mobiele Virtuele Netwerk Enabler], heeft JUNO Software SRL gekozen om een aangepast platform Read more.....

Effortel, einer der weltweit führenden MVNEs, wählt JUNO Software für die Entwicklung von ...

BUCHAREST, Rumänien, September 13, 2018 /PRNewswire/ -- Effortel, der preisgekrönte globale MVNE, entschied sich für JUNO Software SRL zur Entwicklung und Implementierung einer maßgeschneiderten S...

PubMed Articles [433 Associated PubMed Articles listed on BioPortfolio]

Histological and electron microscopy observations on the testis and spermatogenesis of the butterfly Dione juno (Cramer, 1779) and Agraulis vanillae (Linnaeus, 1758) (Lepidoptera: Nymphalidae).

Lepidopteran species present an interesting case of sperm polymorphism and testicular fusion. The study of these features are of great importance in understanding the reproductive biology of these ins...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Clinical Trials [155 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

This study will provide long-term follow-up for patients who have received treatment with a Juno CAR T-cell product in a Juno-sponsored clinical trial. In this study, patients will be foll...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1255 Associated Companies listed on BioPortfolio]

Juno Therapeutics, Inc.

About Opus Bio

Juno Online Services, Inc.

Juno is a nationwide ISP offering consumers a choice of 3 low price dial up Internet access options to meet their budget and personal Internet access needs. Juno Platinum Internet service offers a val...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Juno Therapeutics, Inc." on BioPortfolio

We have published hundreds of Juno Therapeutics, Inc. news stories on BioPortfolio along with dozens of Juno Therapeutics, Inc. Clinical Trials and PubMed Articles about Juno Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Juno Therapeutics, Inc. Companies in our database. You can also find out about relevant Juno Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record